Journal article
Morphine reduced perceived anger from neutral and implicit emotional expressions
- Abstract:
- The μ-opioid system modulates responses to pain and psychosocial stress and mediates non-social and social reward. In humans, the μ-opioid agonist morphine can increase overt attention to the eye-region and visual exploration of faces with neutral expressions. However, little is known about how the human μ-opioid system influences sensitivity to and appraisal of subtle and explicit cues of social threats and reward. Here, we examined the effects of selective μ-opioid stimulation on perception of anger and happiness in faces with explicit, neutral or implicit emotion expressions. Sixty-three healthy adults (32 females) attended two sessions where they received either placebo or 10 mg per oral morphine in randomised order under double-blind conditions. Based on the known μ-opioid reduction of pain and discomfort, as well as reports suggesting that the non-specific partial agonist buprenorphine or the non-specific antagonist naltrexone affect appraisal of social emotional stimuli, we hypothesised that morphine would reduce threat sensitivity and enhance perception of happy facial expressions. While overall perception of others’ happiness was unaffected by morphine treatment, morphine reduced perception of anger in stimuli with neutral and implicit expressions without affecting perception of explicit anger. This effect was statistically unrelated to gender, subjective drug effects, mood and autism trait measures. The finding that a low dose of μ-agonist reduced the propensity to perceive anger in photos with subtle facial expressions is consistent with the notion that μ-opioids mediate social confidence and reduce sensitivity to threat cues.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 474.5KB, Terms of use)
-
- Publisher copy:
- 10.1016/j.psyneuen.2018.02.035
Authors
- Publisher:
- Elsevier
- Journal:
- Psychoneuroendocrinology More from this journal
- Volume:
- 91
- Pages:
- 123-131
- Publication date:
- 2018-03-01
- Acceptance date:
- 2018-02-28
- DOI:
- EISSN:
-
1873-3360
- ISSN:
-
0306-4530
- Keywords:
- Pubs id:
-
pubs:943637
- UUID:
-
uuid:8fe38a9e-858b-4102-b0ac-ecce7426d173
- Local pid:
-
pubs:943637
- Source identifiers:
-
943637
- Deposit date:
-
2018-11-16
Terms of use
- Copyright holder:
- Elsevier Ltd
- Copyright date:
- 2018
- Notes:
- © 2018 Elsevier Ltd. All rights reserved. This is the accepted manuscript version of the article. The final version is available online from Elsevier at: https://doi.org/10.1016/j.psyneuen.2018.02.035
If you are the owner of this record, you can report an update to it here: Report update to this record